ADHD Medication UK: A Complete Guide to Treatment Options

If you or your child has recently received an ADHD diagnosis, one of the first questions is usually: what treatment is actually available? In the UK, ADHD medication is often a core component of an evidence-based treatment plan — but understanding which medications exist, how they work, and how to access them through the NHS or privately can feel overwhelming. This guide, written by Consultant Psychologist Adeel Sarwar, walks you through everything you need to know about ADHD medication in the UK.

Do I Need Medication for ADHD?

Not everyone with ADHD requires medication, and the decision should always be made collaboratively between you, your family (where relevant), and a qualified clinician. NICE Clinical Guideline NG87 recommends a stepped-care approach: psychological therapies, psychoeducation, and environmental modifications are considered first — particularly for children under five. However, for moderate-to-severe ADHD, medication combined with behavioural support is consistently shown to produce the best outcomes.

For school-age children and adults with significant functional impairment, NICE recommends that drug treatment should be offered as a first-line option alongside or before psychological intervention, particularly when access to therapies is limited.

Types of ADHD Medication Available in the UK

ADHD medications fall into two main categories: stimulants and non-stimulants. Both are licensed and available in the UK, though prescribing pathways differ depending on your age and whether you are accessing care through the NHS or privately.

Stimulant Medications

Stimulants are the most commonly prescribed ADHD medications in the UK and carry the strongest evidence base. They work by increasing the availability of dopamine and norepinephrine in the prefrontal cortex — neurotransmitters that play a central role in attention, impulse control, and executive function.

Methylphenidate is the first-line stimulant for children and adolescents in England. Common brand names include Ritalin, Concerta XL, Equasym XL, and Medikinet. It comes in short-acting formulations (lasting 4–6 hours) and modified-release preparations (lasting 8–12 hours). Most children are started on a modified-release version to avoid the need for a dose at school. Methylphenidate is listed on the NHS formulary and, once prescribed by a specialist, can typically be continued by a GP under a Shared Care Agreement.

Lisdexamfetamine (Vyvanse / Elvanse) is the first-line pharmacological treatment for adults with ADHD in the UK, as recommended by NICE (NG87, updated 2019). Unlike methylphenidate, lisdexamfetamine is a prodrug: it is converted to active dexamphetamine in the body, producing a smoother onset and a longer duration of action — typically 12–14 hours. This makes it particularly suited to adults managing demanding working days. Clinical trials published in the British Journal of Psychiatry have consistently demonstrated significant reductions in ADHD symptoms and improvements in quality of life with lisdexamfetamine in adults.

Dexamphetamine (immediate-release) may be prescribed where lisdexamfetamine is not tolerated, when more flexible dosing is required, or where the patient has a longer history with the drug. It remains an effective option for both children and adults in specific clinical circumstances.

Non-Stimulant Medications

Non-stimulants are typically considered when stimulants are not effective, not tolerated, or contraindicated — for example, in people with certain cardiac conditions, a personal or family history of stimulant misuse, or co-occurring anxiety disorders that are worsened by stimulants.

Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor (SNRI) licensed for ADHD in both children and adults in the UK. It is non-stimulant and non-controlled, which can be an advantage in certain clinical contexts. The trade-off is that it takes 4–8 weeks to reach full therapeutic effect — making it less suitable for those who need rapid symptom relief. It is particularly useful for patients with comorbid anxiety or tic disorders.

Guanfacine (Intuniv) is a non-stimulant option licensed for children and adolescents aged 6–17 in the UK. It acts on alpha-2A adrenergic receptors in the prefrontal cortex and has been shown in randomised controlled trials to improve hyperactivity, impulsivity, and inattention. Guanfacine is often used as an adjunct to stimulant therapy or as a standalone treatment when stimulants are not appropriate.

How to Get an ADHD Prescription in the UK

In the UK, ADHD medications — particularly stimulants — are classified as Schedule 2 Controlled Drugs under the Misuse of Drugs Regulations 2001. This means they can only be initiated by a specialist: typically a consultant psychiatrist, paediatrician, or nurse prescriber with specialist ADHD accreditation. GPs cannot initiate these prescriptions, though they may take over ongoing prescribing under a Shared Care Agreement once the patient is stable.

NHS Pathway

The typical NHS route in England follows these steps:

1. Speak with your GP and request a referral for an ADHD assessment.
2. Be assessed by an NHS ADHD specialist. Current waiting times in many parts of England exceed two to five years for adult ADHD services.
3. If a diagnosis is confirmed, the specialist initiates medication and oversees a titration period.
4. Once the dose is stabilised, your GP may accept a Shared Care Agreement to prescribe ongoing medication, with annual reviews by the specialist.

It is worth noting that NHS England's Right to Choose policy allows patients to request assessment by an alternative qualified provider — such as Psychiatry UK or ADHD 360 — at NHS cost. This can significantly reduce waiting times and is a route many patients are not told about by their GP.

Private Assessment and Prescribing

Private ADHD assessments are available from a range of regulated providers across the UK. Following a confirmed private diagnosis, a private psychiatrist can prescribe medication directly. Some GPs will accept a Shared Care Agreement from a private provider (meaning the NHS takes over ongoing prescriptions); others will not. If your GP declines, you may need to continue private prescriptions — a cost that can range from £80–£200 per month depending on the medication and provider.

Titration: Finding the Right Dose

Starting ADHD medication is not a one-size-fits-all process. Titration — the process of gradually adjusting the dose to find the level that provides maximum benefit with minimum side effects — typically takes 4–12 weeks. Your clinician will start at a low dose and increase incrementally, monitoring response at each stage. You may be asked to complete standardised rating scales (such as the Conners Scale or ADHD-RS) and to track changes in sleep, appetite, mood, and heart rate. Do not self-adjust your dose between reviews: small changes can have significant effects.

Common Side Effects and What to Watch For

All ADHD medications carry potential side effects. The most commonly reported include:

• Reduced appetite — most pronounced in the hours following the morning dose; can impact growth in children with long-term use and should be monitored.
• Sleep difficulties — particularly with late afternoon doses of long-acting stimulants. Good sleep hygiene and timing adjustments often resolve this.
• Elevated heart rate and blood pressure — requires baseline cardiovascular assessment and ongoing monitoring, particularly in those with pre-existing cardiac conditions.
• Irritability or emotional lability — sometimes observed as the medication wears off ("rebound effect"), and can often be managed with dose timing or formulation changes.
• Headaches and stomach aches — usually transient and most common in the first two to four weeks of treatment.

Serious adverse events are rare but should be taken seriously. Your prescriber should document a baseline assessment of height, weight, blood pressure, and pulse before starting medication and review these at every appointment.

ADHD Medication for Adults vs. Children: Key Differences

While the underlying pharmacology is the same, there are important differences in how ADHD medication is prescribed and used across the lifespan. Lisdexamfetamine is now the preferred first-line option for adults in the UK, whereas methylphenidate remains the standard starting point for children and adolescents. Adults are also more likely to present with comorbidities — including depression, anxiety, and substance use disorders — that influence medication selection and require careful clinical consideration.

A landmark study published in The Lancet Psychiatry (2022) found that adults with ADHD who received pharmacological treatment showed significantly lower rates of criminal convictions, accidents, and substance misuse compared to untreated controls — underscoring the substantial life-impact of effective, ongoing treatment.

Medication Is Only Part of the Picture

Medication can make a dramatic difference to attention, impulse control, and daily functioning — but it works best as part of a comprehensive treatment plan. Cognitive behavioural therapy (CBT) adapted for ADHD, ADHD coaching, psychoeducation, and reasonable adjustments in educational or workplace settings all contribute to long-term outcomes. For children, NICE-recommended parent training programmes have been shown to be transformative, even in the absence of medication. Medication and psychological support are not either/or choices — they are most powerful in combination.

Frequently Asked Questions About ADHD Medication in the UK

Is ADHD medication addictive?

When used as prescribed and at therapeutic doses, stimulant ADHD medications are not considered addictive. They are controlled substances, and misuse carries genuine risks — but research consistently shows that treating ADHD pharmacologically in adolescence actually reduces the likelihood of later substance misuse, not the reverse. The concern about addiction, while understandable, should not be a reason to avoid effective treatment when it is clinically indicated.

Can I take ADHD medication on weekends or during school holidays?

Yes. Some families choose planned medication holidays — typically during weekends or school breaks — to improve appetite and support growth in children. Whether this is appropriate depends on the individual: some children struggle significantly without medication even outside school. Adults often find that continuous dosing is more effective for managing professional and social demands. Always discuss changes to your medication schedule with your prescriber rather than stopping independently.

How long will I need to take ADHD medication?

ADHD is a lifelong neurodevelopmental condition for many people, and medication needs vary over time. Some individuals reduce or discontinue medication in adulthood as they develop effective coping strategies or their circumstances change; others benefit from continued treatment indefinitely. NICE recommends that medication is reviewed at least annually to assess ongoing need, response, and tolerability.

Can ADHD medication make symptoms worse?

It can, particularly during the titration phase or if the dose is too high. Symptoms such as increased anxiety, irritability, emotional blunting, or worsening sleep should be reported promptly to your prescriber — these are signals that the dose needs adjusting or the medication needs changing. Do not stop stimulant medication abruptly without speaking to your doctor first.

Is ADHD medication free on the NHS?

Yes — once prescribed via the NHS, ADHD medications are dispensed on standard NHS prescriptions. Adults in England pay the standard prescription charge (currently £9.90 per item as of 2024–25); children under 16, full-time students under 19, and adults on qualifying benefits are exempt. A Prescription Prepayment Certificate (PPC) can significantly reduce costs if you pay for multiple prescription items.

What happens if my GP won't prescribe my ADHD medication?

This is unfortunately a common issue, particularly for adults who have received private diagnoses. If your GP declines to enter into a Shared Care Agreement, you have several options: continue private prescriptions, request a second GP opinion, raise a formal concern with NHS England, or contact organisations such as ADHD UK for guidance and advocacy support.

Take the First Step

Understanding whether ADHD may be affecting your life — or your child's — is the essential first step before any treatment decision. Our validated online ADHD self-assessment tool, developed with clinical input, can help you reflect on your symptoms and decide whether a formal professional evaluation is the right move.

Take the free ADHD self-assessment →

Reviewed and written by Adeel Sarwar, Consultant Psychologist (DClinPsy, HCPC Registered, MBPsS). Adeel has over 15 years of experience in neurodevelopmental assessment across NHS and independent settings, specialising in ADHD and autism across the lifespan. He is a member of the British Psychological Society and is committed to evidence-based, compassionate care.

References

• National Institute for Health and Care Excellence (2019). Attention deficit hyperactivity disorder: diagnosis and management (NG87). nice.org.uk/guidance/ng87
• Kooij, J.J.S. et al. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry, 56, 14–34.
• Chang, Z. et al. (2017). Medication for ADHD and risk for depression. Biological Psychiatry, 80(12), 916–922.
• NHS England (2024). Right to Choose: accessing ADHD services. england.nhs.uk
• Lichtenstein, P. et al. (2012). Medication for ADHD and criminality. New England Journal of Medicine, 367(21), 2006–2014.

Written & clinically reviewed by

Dr Marc Mandell

LPCC · Licensed Professional Clinical Counselor

LPCC Licensed 15+ Years Experience

Dr Mandell is a Licensed Professional Clinical Counselor with over 15 years of experience specialising in adult ADHD assessment and cognitive behavioural approaches. Full profile →